Area of research
Virology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, and SARS-CoV-2 and COVID-19 Research.
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes
Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses
CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Electron tomography visualization of HIV-1 fusion with target cells using fusion inhibitors to trap the pre-hairpin intermediate
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
Structural basis for germline antibody recognition of HIV-1 immunogens
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117